共 86 条
[1]
Ahdoot M(2022)Using prostate imaging-reporting and data system (PI-RADS) scores to select an optimal prostate biopsy method: a secondary analysis of the trio study Eur Urol Oncol 5 176-186
[2]
Lebastchi AH(2017)Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study Lancet 389 815-822
[3]
Long L(2021)Beyond the learning curve of prostate MRI/TRUS target fusion biopsy after more than 1000 procedures Urology 155 39-45
[4]
Ahmed HU(2022)Prostate biopsy in the era of MRI-targeting: towards a judicious use of additional systematic biopsy Eur Radiol 2 2-18
[5]
El-Shater Bosaily A(2019)Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer Cochrane Database Syst Rev 4 12663-920
[6]
Brown LC(2022)Clinically localized prostate cancer: AUA/ASTRO guideline, part i: introduction, risk assessment, staging, and risk-based management J Urol 208 10-179
[7]
Checcucci E(2021)MRI-targeted or standard biopsy in prostate cancer screening N Engl J Med 385 908-169
[8]
Piramide F(2018)The combination of targeted and systematic prostate biopsies is the best protocol for the detection of clinically significant prostate cancer Scand J Urol 52 174-551
[9]
Amparore D(2013)Active surveillance: does serial prostate biopsy increase histological inflammation? Prostate Cancer Prostatic Dis 16 165-2137
[10]
Deniffel D(2019)Characterizing the learning curve of MRI-US fusion prostate biopsies Prostate Cancer Prostatic Dis 22 546-140